Catalogue/Peptides
RETATRUIDE
Triple agonist peptide targeting GIP, GLP-1 and glucagon receptors, used in metabolic and energy-expenditure research models.
Purity
99.1%
Pack
1 vial per carton
Strength
10 mg / vial
- ✓No minimum order
- ✓Discreet neutral packaging with tracking
- ✓Every lot independently tested, certificate included
- ✓Filled and sealed in Switzerland
Compound profile
Retatrutide (LY3437943) is a single peptide that activates three receptors: GIP, GLP-1 and glucagon. A C20 fatty-acid side chain extends its half-life.
It is one of the most studied next-generation metabolic peptides, researched for body weight, energy expenditure and liver fat.
Alpine Pharma supplies RETATRUIDE at 99.1% purity, verified by HPLC and mass spectrometry. Each lot is released only after independent assay and ships with its certificate of analysis.
- Full name
- Retatrutide
- Synonyms
- LY3437943, GGG tri-agonist
- Sequence
- 39 aa GIP/GLP-1/glucagon tri-agonist, C20 diacid lipidated
- Molecular formula
- C221H342N46O68
- Molecular weight
- 4731.3 g/mol
- CAS number
- 2381089-83-2
- Peptide length
- 39 amino acids
- Form
- Lyophilised powder
- Purity
- 99.1%
- Appearance
- White lyophilised powder
- Solubility
- Soluble in bacteriostatic or sterile water
For laboratory research use only. Not for human or veterinary use. Sold exclusively for in-vitro and preclinical research.
